Heparin Sodium Injection Shortage: Supply Updates and Manufacturer Status

What’s in Shortage

Heparin Sodium Injection, a medication used in the therapeutic category of hematology, is currently listed as in shortage. This includes products labeled as Heparin Sodium and Heparin Sodium in Sodium Chloride. The shortage affects various presentations of the injection dosage form. This status was first posted on November 14, 2017, and was most recently updated on February 5, 2026.

Which Manufacturers Are Affected

Several manufacturers are involved in the production of Heparin Sodium Injection, with varying levels of availability:

• B. Braun Medical Inc. (800-227-2862):

  • Available: Heparin Sodium 1,000 Units In Sodium Chloride 0.9% (NDC 0264-9872-10)
  • Available: Heparin Sodium 2,000 Units in Sodium Chloride 0.9% (NDC 0264-9872-00)

• Baxter Healthcare (888-229-0001):

  • Available: Heparin Sodium In Sodium Chloride (NDC 0338-0433-04)
  • Unavailable: Heparin Sodium In Sodium Chloride (NDC 0338-0424-18). Note: This product has been discontinued and replaced by Product Code 2B0953.
  • Unavailable: Heparin Sodium In Sodium Chloride (NDC 0338-0431-03). Estimated recovery is March 2026.

• Fresenius Kabi USA, LLC (888-386-1300):

  • Available: Heparin Sodium (NDC 63323-519-77). The manufacturer suggests checking wholesalers for inventory.
  • Unavailable: Heparin Sodium (NDC 63323-519-10). The next release is expected in February 2026. Check wholesalers for current inventory.

Why There’s a Shortage

No specific reason for the overall shortage was provided in the source data. However, individual manufacturer notes indicate that certain presentations have been discontinued or are facing temporary supply gaps with estimated recovery dates in early 2026.

What Patients Should Do

If you or a loved one relies on Heparin Sodium Injection, please consider the following steps:

• Consult your healthcare provider: Discuss your treatment plan and any concerns regarding medication availability.
• Speak with your pharmacist: Pharmacists can check current inventory across different wholesalers and may have information on which specific presentations are currently in stock.
• Contact manufacturers: You may use the contact information provided above to inquire about the most up-to-date availability for specific NDCs.

Disclaimer: Patients should always consult their healthcare provider for medical advice and before making any changes to their medication or treatment regimen.

Source

Information provided by the FDA Drug Shortage Database.